Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol
Riccardo Caccialanza M.D. Alessandro Laviano M.D. Federica Lobascio M.D. Elisabetta Montagna R,D Raffaele Bruno M.D. Serena Ludovisi M.D. Angelo Guido Corsico M.D., Ph.D. Antonio Di Sabatino M.D. Mirko Belliato M.D. Monica Calvi Pharm .D. IsabellaIacona Pharm .D. Giuseppina Grugnetti R.N. Elisa Bonadeo M.D. Alba Muzzi M.D. Emanuele Cereda M.D. Ph.D.
Abstract
Beginning in December 2019, the 2019 novel coronavirus disease (COVID-19) has caused a pneumonia epidemic that began in Wuhan, China, and is rapidly spreading throughout the whole world. Italy is the hardest hit country after China. Oral supplementation of whey proteins as well as intravenous infusion of multivitamin, multimineral trace elements solutions are implemented at admission. In the presence of 25-hydroxyvitamin D deficit, cholecalciferol is promptly supplied. If nutritional risk is detected, two to three bottles of protein-calorie oral nutritional supplements (ONS) are provided. If <2 bottles/d of ONS are consumed for 2 consecutive days and/or respiratory conditions are worsening, supplemental/total parenteral nutrition is prescribed.
No comments:
Post a Comment